JPWO2022032166A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022032166A5 JPWO2022032166A5 JP2023507949A JP2023507949A JPWO2022032166A5 JP WO2022032166 A5 JPWO2022032166 A5 JP WO2022032166A5 JP 2023507949 A JP2023507949 A JP 2023507949A JP 2023507949 A JP2023507949 A JP 2023507949A JP WO2022032166 A5 JPWO2022032166 A5 JP WO2022032166A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- polypeptide
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062919P | 2020-08-07 | 2020-08-07 | |
| US63/062,919 | 2020-08-07 | ||
| PCT/US2021/045062 WO2022032166A1 (en) | 2020-08-07 | 2021-08-06 | Multiepitope vaccine for the treatment of alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023536995A JP2023536995A (ja) | 2023-08-30 |
| JPWO2022032166A5 true JPWO2022032166A5 (https=) | 2025-08-19 |
| JP2023536995A5 JP2023536995A5 (https=) | 2025-08-19 |
Family
ID=80118546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507949A Pending JP2023536995A (ja) | 2020-08-07 | 2021-08-06 | アルツハイマー病を処置するためのマルチエピトープワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250186567A1 (https=) |
| EP (1) | EP4192497A4 (https=) |
| JP (1) | JP2023536995A (https=) |
| KR (1) | KR20230080397A (https=) |
| CN (1) | CN116472055A (https=) |
| AR (1) | AR123188A1 (https=) |
| AU (1) | AU2021321549A1 (https=) |
| CA (1) | CA3188456A1 (https=) |
| IL (1) | IL300347A (https=) |
| MX (1) | MX2023001503A (https=) |
| TW (1) | TW202221017A (https=) |
| WO (1) | WO2022032166A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021236809A2 (en) * | 2020-05-19 | 2021-11-25 | Othair Prothena Limited | Multi-epitope vaccine for the treatment of alzheimer's disease |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| IL301262A (en) * | 2020-09-18 | 2023-05-01 | Othair Prothena Ltd | Multiepitope vaccine for the treatment of alzheimer's disease |
| CN115925987A (zh) * | 2022-02-28 | 2023-04-07 | 安域生物科技(杭州)有限公司 | 基于β-淀粉样蛋白修饰的抗原多肽及其应用 |
| CU20230023A7 (es) | 2023-05-12 | 2024-12-09 | Ct Ingenieria Genetica Biotecnologia | Antígeno quimérico multiblanco para la inmunoterapia de la enfermedad de alzheimer |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208036A (en) | 1985-01-07 | 1993-05-04 | Syntex (U.S.A.) Inc. | N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| WO1994012629A1 (en) | 1992-12-02 | 1994-06-09 | Baylor College Of Medicine | Episomal vectors for gene therapy |
| AU698962B2 (en) | 1993-09-14 | 1998-11-12 | Epimmune, Inc. | Alteration of immune response using pan DR-binding peptides |
| US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
| US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| WO2004044195A2 (en) * | 2002-11-12 | 2004-05-27 | Risø National Laboratory | Polynucleotides encoding agmatine coumaroyltransferase (act) and uses thereof |
| KR20120017469A (ko) | 2007-01-05 | 2012-02-28 | 유니버시티 오브 취리히 | 질환 특이적 결합 분자 및 표적을 제공하는 방법 |
| ES2656442T3 (es) * | 2011-09-19 | 2018-02-27 | Axon Neuroscience Se | Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer |
| CA2885924C (en) * | 2012-08-21 | 2022-12-13 | Institute For Molecular Medicine, Inc. | Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein |
| CA2902026C (en) | 2013-03-13 | 2023-08-29 | Prothena Biosciences Limited | Tau immunotherapy |
| CA3003483C (en) | 2015-11-06 | 2022-09-13 | Adjuvance Technologies, Inc. | Triterpene saponin analogues |
| EP3452507B1 (en) | 2016-05-02 | 2022-10-19 | Prothena Biosciences Limited | Tau immunotherapy |
| PE20190208A1 (es) | 2016-05-02 | 2019-02-07 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau |
| CA3022515A1 (en) | 2016-05-02 | 2017-11-09 | Prothena Biosciences Limited | Antibodies recognizing tau |
| EP3609505A4 (en) | 2017-04-13 | 2021-04-28 | Adjuvance Technologies, Inc. | TRITERPEN-SAPONIN SYNTHESIS, INTERMEDIATES AND COMBINATIONS OF ADJUVANCES |
| CN110730666A (zh) | 2017-04-25 | 2020-01-24 | 佐剂技术公司 | 三萜皂苷类似物 |
| CN110881274B (zh) | 2017-05-02 | 2024-11-15 | 普罗塞纳生物科学有限公司 | 识别tau的抗体 |
| WO2019079160A1 (en) | 2017-10-16 | 2019-04-25 | Adjuvance Technologies, Inc. | TRITERPENIC SAPONIN ANALOGS |
| GB201803387D0 (en) * | 2018-03-02 | 2018-04-18 | One Health Ventures Ltd | Disease detection |
| CN109022460B (zh) * | 2018-08-31 | 2021-05-28 | 西藏自治区农牧科学院农业研究所 | 一种bahd酰基转移酶基因及其用途 |
-
2021
- 2021-08-06 KR KR1020237007790A patent/KR20230080397A/ko active Pending
- 2021-08-06 JP JP2023507949A patent/JP2023536995A/ja active Pending
- 2021-08-06 US US18/020,034 patent/US20250186567A1/en active Pending
- 2021-08-06 EP EP21853506.0A patent/EP4192497A4/en active Pending
- 2021-08-06 WO PCT/US2021/045062 patent/WO2022032166A1/en not_active Ceased
- 2021-08-06 AU AU2021321549A patent/AU2021321549A1/en active Pending
- 2021-08-06 CA CA3188456A patent/CA3188456A1/en active Pending
- 2021-08-06 CN CN202180067903.XA patent/CN116472055A/zh active Pending
- 2021-08-06 MX MX2023001503A patent/MX2023001503A/es unknown
- 2021-08-06 IL IL300347A patent/IL300347A/en unknown
- 2021-08-09 TW TW110129345A patent/TW202221017A/zh unknown
- 2021-08-09 AR ARP210102219A patent/AR123188A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI379839B (en) | Aβ immunogenic peptide carrier conjugates and methods of producing same | |
| EP0652896B1 (en) | Peptide compounds | |
| US20030095979A1 (en) | Pharmaceutical preparations comprising modified peptides | |
| US9849174B2 (en) | Methods and compositions related to immunogenic fibrils | |
| US20030175285A1 (en) | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | |
| JPWO2021236809A5 (https=) | ||
| US20050049197A1 (en) | Induction of immune response against desired determinants | |
| KR20220062080A (ko) | 전립선암 치료를 위한 면역요법 | |
| JPWO2022032166A5 (https=) | ||
| US20060233758A1 (en) | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | |
| JPWO2022060488A5 (https=) | ||
| JPWO2022060424A5 (https=) | ||
| JPWO2022031342A5 (https=) | ||
| Gras-Masse | Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations | |
| KR100887591B1 (ko) | 특정의 교차 반응성을 증가시키는 항원성 구조들의 제조방법 | |
| CA2363118A1 (en) | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d | |
| WO1997049425A1 (en) | Vaccine comprising antigens bound to carriers through labile bonds | |
| CA2696068A1 (en) | Compositions and methods for the treatment and prophylaxis of hypertension | |
| JPWO2022060487A5 (https=) | ||
| Horváth et al. | A lipophilic adjuvant carrier system for antigenic peptides | |
| US20050255561A1 (en) | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | |
| US20090105155A1 (en) | Truncated lhrh formulations | |
| AU2005282231B2 (en) | Truncated LHRH formulations | |
| HK1110082A (en) | Truncated lhrh formulations | |
| RU2021103287A (ru) | Самособирающийся пептидный каркас |